EyePoint (EYPT) Pharmaceuticals announced that it has commenced an underwritten public offering of $150M of shares of its common stock. All of the shares are being offered by EyePoint. J.P. Morgan, Jefferies, Citigroup, and Guggenheim Securities are acting as joint book running managers for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EYPT:
- EyePoint Pharmaceuticals Launches Phase 3 DURAVYU Program
- EyePoint files automatic mixed securities shelf
- EyePoint initiates Duravyu program, announces preclinical vorolanib data
- EyePoint reports inducement grants under NASDAQ listing rule
- EyePoint Pharmaceuticals Completes Promising Study on EYP-1901 for Diabetic Retinopathy